PETER RICHARDSON to Drug Evaluation, Preclinical
This is a "connection" page, showing publications PETER RICHARDSON has written about Drug Evaluation, Preclinical.
Connection Strength
0.080
-
JAK inhibition reduces SARS-CoV-2 liver infectivity and modulates inflammatory responses to reduce morbidity and mortality. Sci Adv. 2021 01; 7(1).
Score: 0.041
-
Mechanism of baricitinib supports artificial intelligence-predicted testing in COVID-19 patients. EMBO Mol Med. 2020 08 07; 12(8):e12697.
Score: 0.039